CIK 0001660334
- Non-accelerated filer
- Smaller reporting company
Verrica Pharmaceuticals Inc.
Sign in to watch- Ticker
- VRCA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 463137900
- Phone
- +1 484-453-3300
- Business address
- 44 WEST GAY STREET, SUITE 400, WEST CHESTER, PA
- 4 Derivatives Options or other derivatives
- 4 Open-market buy President and CEO bought 4,000 shares at $9.95 ($39,800)
- 4 Open-market buy Chief Legal Officer bought 2,500 shares at $9.79 ($24,475)
- 4 Open-market buy Chief Financial Officer bought 5,000 shares at $9.89 ($49,450)
- 4 Open-market buy Director bought 739,830 shares at $14.75 ($10,912,493)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 10,000 shares at an average $8.88 ($88,785)
- 4 Open-market buy Director bought 20,000 shares at $9.09 ($181,800)
- 4 Open-market buy Director bought 10,000 shares at $8.55 ($85,500)
- 4 Open-market buy Director bought 6,000 shares at $6.92 ($41,520)
- 4 Open-market buy Director bought 31,250 shares at an average $6.41 ($200,464)
- 4 Open-market buy Chief Financial Officer bought 7,900 shares at $6.24 ($49,296)
- 4 Open-market buy President and CEO bought 10,661 shares at $6.28 ($66,951)
- 4 Open-market buy Director bought 158,500 shares at an average $6.44 ($1,020,985)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 7 of 13 · 253 filings